Women's health supplements — products marketed for menopause support, fertility, hormonal balance, PMS relief, reproductive health, and related categories — occupy one of the most legally complex positions in the dietary supplement market. The claims brands want to make in this space often push against the structure/function vs. disease claim boundary, and FTC scrutiny of efficacy claims in women's health advertising has increased significantly.
The Structure/Function vs. Disease Claim Boundary in Women's Health
The core regulatory principle governing all supplement claims — the structure/function vs. disease claim distinction under FDA's framework — is particularly difficult to navigate in the women's health category because:
Menopause is a natural biological process, but menopausal symptoms (hot flashes, night sweats, mood changes) are clinical conditions for which FDA-approved drugs exist
Fertility is not a disease, but fertility challenges are often associated with clinical conditions (PCOS, endometriosis, thyroid disorders) that are diseases
Hormonal balance is language consumers understand intuitively but FDA does not recognize as a defined clinical endpoint
Permissible Structure/Function Claims
Claim Language | Assessment |
|---|---|
"Supports hormonal balance" | Generally permissible S/F claim if not linked to a specific disease |
"Helps maintain healthy estrogen metabolism" | Generally permissible — affects normal body function |
"Supports a comfortable menopause transition" | Generally permissible — characterizes normal biological process |
"Promotes emotional well-being during hormonal changes" | Generally permissible |
"Supports healthy reproductive function" | Generally permissible |
"Supports healthy menstrual cycle regularity" | Generally permissible if framed around normal cycle |
"Helps maintain healthy progesterone levels already in the normal range" | Permissible — "already in the normal range" qualifier is critical |
Prohibited Disease Claims
Claim Language | Problem |
|---|---|
"Treats hot flashes and night sweats" | "Treats" + symptom of menopausal disorder = disease claim |
"Reduces menopause symptoms" | "Reduces" + "menopause symptoms" = treating a condition |
"Helps women with PCOS maintain regular cycles" | PCOS is a named disease — connecting the claim to PCOS makes it a disease claim |
"Improves fertility" | Fertility impairment is associated with specific medical conditions |
"Relieves PMS symptoms" | PMS as a clinical diagnosis has been recognized by FDA as a condition |
"Regulates hormones in women with hormonal imbalance" | "Hormonal imbalance" as a condition + "regulates" = treating a disease |
"Supports thyroid health in hypothyroid women" | Hypothyroidism is a disease |
Menopause Claims: The Special Challenge
Menopause itself is not a disease — it is a natural biological process. But menopausal disorder and menopausal symptoms are recognized clinical conditions for which FDA-approved treatments exist (hormone replacement therapy, SSRIs for vasomotor symptoms, etc.).
FDA's distinction:
"Supports a comfortable menopause transition" — permissible: refers to the natural process
"Reduces symptoms of menopause" — prohibited: "symptoms of menopause" is disease claim language
"Supports normal hormonal changes during the menopausal years" — permissible: characterizes normal physiology
"Relieves hot flashes" — prohibited: hot flashes are a menopausal symptom/condition
The qualifier "comfort" vs. "relief" / "treatment" / "reduction of symptoms" distinguishes permissible from prohibited language in many cases.
Fertility Claims
Fertility is particularly complex because:
Normal fertility is a function of the body (permissible to reference)
Fertility impairment (infertility) is a condition often caused by specific medical conditions (PCOS, endometriosis, premature ovarian insufficiency)
Claims that connect a supplement to helping women conceive imply treatment of infertility in consumers who are trying to conceive (i.e., facing a fertility challenge)
Generally permissible:
"Supports reproductive health"
"Provides nutritional support for women trying to conceive"
"Contains nutrients important for fertility" (if accurate and not overstated)
Higher risk:
"Improves chances of conception"
"Supports fertility" (the word "fertility" itself is not prohibited but context matters)
Any claim that references specific fertility conditions (PCOS, endometriosis, premature ovarian insufficiency)
FTC Substantiation Requirements for Women's Health Claims
FTC's substantiation standard (competent and reliable scientific evidence) applies to all advertising claims for women's health supplements. Key FTC considerations for this category:
High-scrutiny claims:
Hormone level effects (estrogen, progesterone, testosterone)
Cycle regularity or normalization
Fertility or conception support
Weight management claims with hormonal mechanism
Evidence quality issues common in women's health:
Studies conducted only in women with abnormal hormone levels (not representative of general supplement users)
Studies using pharmaceutical-grade preparations not comparable to the commercial supplement dose
Studies with clinically relevant endpoints (actual fertility outcomes) vs. surrogate endpoints (hormone marker changes)
FTC has brought enforcement actions in the women's health space targeting weight loss claims tied to "hormonal balance" mechanisms, fertility claims with insufficient substantiation, and PCOS-related claims made by brands without adequate RCT evidence.
Disclaimer Requirements
All structure/function claims on dietary supplement labels require the 21 CFR 101.93 disclaimer:
"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
The disclaimer must appear adjacent to the claim, in bold type, in type size at least half that of the claim. It does not appear in advertising — but it must appear on the product label and in any labeling that makes the S/F claim.
Influencer and Social Media Marketing Risks
Women's health supplements are heavily marketed through social media and influencer partnerships. Common risks:
Influencers sharing personal health stories that constitute disease claims (e.g., "I was diagnosed with PCOS and this supplement helped regulate my cycle")
Before/after fertility testimonials implying the supplement caused conception
Influencer content that the brand reposts or amplifies (making the brand responsible for the claim)
TikTok and Instagram content with disease claim language that is technically "user generated" but was paid for or coordinated by the brand
Under FTC's endorsement guidance (FTC Endorsement Guides), a brand that pays or provides free product to an influencer who makes disease claims is responsible for those claims.
How Truli Helps with Women's Health Claim Compliance
S/F vs. disease claim analysis: Truli scans label copy, website content, social media, and influencer content for women's health claim language that may cross into disease territory
Menopause and fertility claim flagging: Truli applies category-specific guidance to identify high-risk language in the menopause, fertility, and hormonal health areas
Influencer content monitoring: Truli monitors influencer content for paid or coordinated partnerships and flags disease claim language in influencer posts the brand amplifies
Pre-launch claim review: Truli reviews planned claim language for new women's health products before launch to identify FDA and FTC risk
Related Regulations
FDA Drug-Supplement Boundary — How disease claims make a supplement an unapproved drug
FDA Structure/Function Claims for Supplements — The framework for permissible S/F claims
21 CFR 101.93 — S/F Claim Disclaimer — Required disclaimer for all S/F claims
FTC Substantiation Standard for Supplements — FTC's evidence requirements for supplement advertising claims
FTC Endorsement Guides — Influencer Marketing — Disclosure requirements for influencer content
Frequently Asked Questions
Can we say "supports healthy estrogen levels"?
Generally yes — with appropriate context. "Supports healthy estrogen levels" as a structure/function claim is permissible if it does not imply treating an abnormal condition. Adding "already within the normal range" (similar to cholesterol claims) strengthens the S/F characterization.
A customer left a review saying our product helped her get pregnant. Can we repost that?
Reposting or highlighting that testimonial is high risk. A testimonial connecting your supplement to a fertility outcome — particularly one that uses language like "helped me get pregnant" — may constitute an implied fertility efficacy claim. If you have FTC-required disclosures and substantiation to support the implication, reposting may be permissible; if you don't, amplifying the testimonial creates liability.
We want to target our product to women with PCOS. Is that allowed?
Targeting marketing to women with PCOS is legally significant. If you market to women with PCOS and your product claims to "support hormonal balance" or "support healthy cycles," FDA may evaluate the combination of the target audience and the claim as a disease claim — because in the context of PCOS, "hormonal balance" implies treating PCOS. Targeting healthy women and making general structure/function claims is lower risk than targeting disease populations with claims about the relevant disease symptoms.
A note from Truli: Truli is not a law firm, and this article does not constitute or contain legal advice or create an attorney-client relationship. When determining your obligations and compliance with respect to relevant laws and regulations, you should consult a licensed attorney.
Last updated: April 2026. Women's health supplement claims remain a high-enforcement-priority area for both FDA and FTC. Book a demo to see how Truli monitors supplement claim compliance.
